Skip to main content
ANRO logo
ANRO
(NYSE)
Alto Neuroscience, Inc.
$21.68-- (--)
Loading... - Market loading

Alto Neuroscience (ANRO) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Alto Neuroscience Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Alto Neuroscience, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Revenue & Gross Profit
Revenue0.000.000.000.000.21
Cost of Revenue0.000.500.370.340.15
Gross Profit0.00-0.50-0.37-0.340.07
Operating Expenses
Research & Development45.6247.0030.2923.698.37
Selling, General & Administrative20.7521.617.525.503.75
Operating Expenses66.3668.1137.8129.1912.12
Operating Income-66.36-68.61-37.81-29.19-12.06
Other Income/Expense
Interest Income6.608.852.350.110.00
Interest Expense2.47-1.381.370.000.00
Other Income/Expense-1.017.181.501.372.87
Income
Income Before Tax-63.24-61.43-36.31-27.71-9.19
Income Tax Expense0.000.000.000.000.00
Net Income-63.24-61.43-36.31-27.71-9.19
Net Income - Continuous Operations-63.24-61.43-36.31-27.71-9.19
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-65.70-68.61-34.56-28.85-9.04
EBIT-66.36-68.61-37.81-29.19-12.27
Depreciation & Amortization0.66-5.800.370.340.15
Earnings Per Share
Basic EPS-2.00-2.00-1.00-8.00-
Diluted EPS--2.00-1.00-8.00-
Basic Shares Outstanding28.8524.6026.883.4525.57
Diluted Shares Outstanding28.8524.6026.883.4525.57

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.